KANORICHEM evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-15T14:01:25.934908+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 9814300000.0
- net_income
- 231200000.0
- operating_cash_flow
- 470700000.0
- free_cash_flow
- -118400000.0
- total_assets
- 11170400000.0
- total_liabilities
- 5441200000.0
- total_equity
- 5729200000.0
- cash
- 104600000.0
- total_debt
- 2912800000.0
- revenue_growth
- -0.36134338944888755
- earnings_growth
- -1.276555023923445
- net_margin
- 0.023557462070652006
- roe
- 0.0403546743000768
- debt_to_equity
- 0.5084130419604831
- cash_conversion
- 2.035899653979239
- free_cash_flow_margin
- -0.012064029018880613
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-cf70f006d157eb84246acd1face7a5ba336d5574253629d88e3fbabbd1ab6668
- Policy
- stock-decisions-v1
- Evidence bundle hash
- a223f4b0285bb955f6a97a20b89e8ec47a5ff2a4b241e23ba8c73d3972e3b3aa
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 8a5a4f5bbaae3520f1a390c37a3d691aa06d94fb29804706341bb6c34abf9483
- daily-price: ffd5266edf4a53f30e79a53eedcd7c80b08b4e0ed5053055b4e7f6e660720952
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 189.02.
- The trailing 5-session price return was -1.21%.
- The trailing 20-session price return was 22.15%.
- The trailing 60-session price return was 48.72%.
- The trailing 250-session price return was 128.73%.
- Average cached traded value over twenty sessions was INR 11,898,148.
- The closing price was -6.68% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-15T14:01:25.934908+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.36134338944888755.
- The cached financial metric net margin is 0.023557462070652006.
- The cached financial metric roe is 0.0403546743000768.
- The cached financial metric debt to equity is 0.5084130419604831.
- The cached financial metric cash conversion is 2.035899653979239.
- The cached financial metric free cash flow margin is -0.012064029018880613.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.